Research Contractor SK Pharmteco heralds completion of 2 API plants in IrelandBy Healthcare Propulsion StaffAugust 19, 20260 The summer of the high-potency active pharmaceutical ingredient (HPAPI) expansion continues, as yet another manufacturing specialist makes inroads to boost…
Research Aurobindo unit, China API maker dinged in latest round of FDA warning lettersBy Healthcare Propulsion StaffAugust 19, 20260 After receiving a checkered regulatory scorecard in 2024, Aurobindo’s sterile injectables and oncology unit is back in the FDA’s crosshairs.…
